Management Practices for Methicillin-Resistant Staphylococcus aureus Bacteremia by Adult Infectious Diseases Physicians | Zendy

Natalie Banniettis | Zendy; Susan E. Beekmann | Zendy; Philip M. Polgreen | Zendy; Shubhi Kaushik | Zendy; Stephan Kohlhoff | Zendy; David N. Gilbert | Zendy; John E. Bennett | Zendy; Margaret R. Hammerschlag | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management Practices for Methicillin-Resistant Staphylococcus aureus Bacteremia by Adult Infectious Diseases Physicians

Author(s) -

Natalie Banniettis,

Susan E. Beekmann,

Philip M. Polgreen,

Shubhi Kaushik,

Stephan Kohlhoff,

David N. Gilbert,

John E. Bennett,

Margaret R. Hammerschlag

Publication year - 2018

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofy093

Subject(s) - daptomycin , medicine , bacteremia , vancomycin , staphylococcus aureus , infectious disease (medical specialty) , methicillin resistant staphylococcus aureus , intensive care medicine , microbiology and biotechnology , disease , antibiotics , bacteria , biology , genetics

To assess current use of vancomycin for methicillin-resistant Staphylococcus aureus bacteremia, we surveyed adult infectious disease physicians. Most respondents reported personal experience with infections failing to respond to vancomycin despite minimum inhibitory concentration data indicating susceptibility. In a hypothetical case of such an infection, most would change to daptomycin with or without other agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research